The objective of this project is to identify effective strategies to help patients with lung cancer manage side effects and achieve optimal adherence to oral targeted therapies. To achieve this objective, we will evaluate the effect of a mobile phone-based intervention (“Penny”), compared to usual care, on adherence to oral targeted therapies using a two-arm randomized controlled trial
Trial participation will last for approximately 15 weeks from enrollment through the final survey and return your electronic pill bottle cap to the study team. Your medical record data will be observed for up to 12 months after you enroll, but not require any activities from you.
There is no direct benefit to the participant in this study. Information learned from this study may help
Study Identifier: 834713
Contact the research team to learn more about this study.